Antidepressants in Pregnancy Don't Affect Newborn Behavior

Share this content:
Antidepressants in Pregnancy Don't Affect Newborn Behavior
Antidepressants in Pregnancy Don't Affect Newborn Behavior

THURSDAY, June 8, 2017 (HealthDay News) -- Use of antidepressants in pregnancy is not associated with increased signs of irritability, difficulty feeding, sleep disturbances, or respiratory problems in infants two to four weeks after birth, according to a study published in the May issue of the Journal of Clinical Psychiatry.

Researchers divided 214 new mothers into three groups: those with a mood disorder who were not using an antidepressant; those who were taking a serotonin reuptake inhibitor antidepressant; and those without a mood disorder who were not on an antidepressant.

At two to four weeks after birth, infants in all three groups had similar rates of irritability, difficulty feeding, sleep disturbances, and respiratory problems, the researchers found. The issues affected three out of 10 babies in each group.

"Most pregnant women are naturally going to worry more about their baby's health than their own, and might forego taking an antidepressant to avoid these neonatal signs," first author Amy Yang, from the Asher Center for the Study and Treatment of Depressive Disorders at the Northwestern University Feinberg School of Medicine in Chicago, said in a university news release. "But with the information from this study, they can be reassured that the baby's behavior at two to four weeks after birth is not likely due to exposure to medication or depression."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths